Colossal Biosciences Funding: $615M Raised, Series C (2026)
Colossal Biosciences is a Biotech company based in Dallas, Texas. It has raised $615M in total funding. Latest round: Series C.
Colossal Biosciences funding overview
Colossal Biosciences is a Biotech company based in Dallas, Texas. Colossal Biosciences has raised $615M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in March 2026. The round record for Colossal Biosciences runs through 2026; nothing later has been disclosed. Investors on record include TWG Global, Breyer Capital, Draper Associates, Thomas Tull, Tim Draper, Tony Robbins and 7 others. 13 distinct backers are named across the disclosed rounds.
Colossal Biosciences at a glance
Total raised
$615M
Latest round
Series C
Latest round date
March 2026
Industry
Biotech
Headquarters
Dallas, Texas
Notable investors
TWG Global, Breyer Capital, Draper Associates, Thomas Tull, Tim Draper, Tony Robbins, Winklevoss Capital Management, Paris Hilton
Frequently asked about Colossal Biosciences funding
How much has Colossal Biosciences raised?
Colossal Biosciences has raised $615M in total disclosed funding across the rounds on record.
Who has invested in Colossal Biosciences?
TWG Global, Breyer Capital, Draper Associates, Thomas Tull, Tim Draper, Tony Robbins are named among the investors backing Colossal Biosciences.
What was the latest Colossal Biosciences funding round?
The most recent disclosed round is a Series C, announced in March 2026.
Where is Colossal Biosciences based?
Colossal Biosciences is based in Dallas, Texas.
What sector does Colossal Biosciences operate in?
Colossal Biosciences is tracked under Biotech from Dallas, Texas, with $615M in disclosed funding.
When did Colossal Biosciences last raise?
The last disclosed Colossal Biosciences round closed in March 2026 at Series C.
Colossal Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Dallas below to benchmark round size and investor mix.
